Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/10/779   
Active ingredient: Eflornithine
Indication: Treatment of familial adenomatous polyposis
Sponsor: Cancer Prevention Pharma Limited
c/o Arnold & Porter (UK) LLP, Tower 42, 25 Old Broad Street, London EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Orphan designation EMEA/OD/141/09 (2010)6646 of 20/09/2010